Cargando…

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors

BACKGROUND: Bone-targeted agents (BTAs) used for the prevention of skeletal-related events (SREs) associated with metastatic bone disease possess different attributes that factor into treatment decisions. OBJECTIVE: The aim of this study was to evaluate preferences of patients, caregivers, and nurse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yi, Arellano, Jorge, Hauber, A. Brett, Mohamed, Ateesha F., Gonzalez, Juan Marcos, Hechmati, Guy, Gatta, Francesca, Harrelson, Stacey, Campbell-Baird, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925690/ https://www.ncbi.nlm.nih.gov/pubmed/26821359 http://dx.doi.org/10.1007/s40271-015-0158-4

Ejemplares similares

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Hechmati, Guy, et al.
Publicado: (2014)

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials
por: Koukakis, Reija, et al.
Publicado: (2016)

Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
por: Body, Jean-Jacques, et al.
Publicado: (2018)

Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
por: von Moos, Roger, et al.
Publicado: (2017)

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
por: Kauf, Teresa L., et al.
Publicado: (2012)

Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
por: Hauber, A Brett, et al.
Publicado: (2011)

Physician preferences for non-metastatic castration-resistant prostate cancer treatment
por: Srinivas, Sandy, et al.
Publicado: (2020)

Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug Development
por: Jalowsky, Maggie, et al.
Publicado: (2023)

Public preferences for the return of research results in genetic research: A conjoint analysis
por: Bollinger, Juli, et al.
Publicado: (2014)

Hemodialysis patients’ preferences for the management of anemia
por: Hauber, Brett, et al.
Publicado: (2017)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

Patient and physician preferences for anticancer drugs for the treatment of metastatic colorectal cancer: a discrete-choice experiment
por: González, Juan Marcos, et al.
Publicado: (2017)

Spousal Caregiving in Community Settings in Canada: Implications for Nursing Professionals
por: Stewart, Stacey
Publicado: (2020)

The Value of Hope: Patients’ and Physicians’ Preferences for Survival in Advanced Non-Small Cell Lung Cancer
por: Hauber, Brett, et al.
Publicado: (2020)

Stated Preference for Cancer Screening: A Systematic Review of the Literature, 1990–2013
por: Mansfield, Carol, et al.
Publicado: (2016)

Exploring Decisional Conflict With Measures of Numeracy and Optimism in a Stated Preference Survey
por: Sutphin, Jessie, et al.
Publicado: (2021)

Quantifying the importance of inhaler attributes corresponding to items in the patient satisfaction and preference questionnaire in patients using Combivent Respimat
por: Davis, Kimberly H., et al.
Publicado: (2017)

Japanese Patients’ and Physicians’ Preferences for Anticoagulant Use in Atrial Fibrillation: Results from a Discrete-choice Experiment
por: Okumura, Ken, et al.
Publicado: (2015)

Communicating Test Results from a General Health Check: Preferences from a Discrete Choice Experiment Survey
por: Grauman, Åsa, et al.
Publicado: (2021)

Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia
por: van Overbeeke, Eline, et al.
Publicado: (2021)

Prevalence of bone metastases and bone-targeting agent use among solid tumor patients in the United States
por: Hernandez, Rohini K, et al.
Publicado: (2015)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in Colombia
por: Graham-Clarke, Peita L, et al.
Publicado: (2020)

Are Gastroenterologists Less Tolerant of Treatment Risks than Patients? Benefit-Risk Preferences in Crohn's Disease Management
por: Johnson, F. Reed, et al.
Publicado: (2010)

Patient and physician preferences for ulcerative colitis treatments in the United States
por: Boeri, Marco, et al.
Publicado: (2019)

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries
por: Body, Jean-Jacques, et al.
Publicado: (2017)

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
por: Mohamed, Ateesha F., et al.
Publicado: (2015)

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States
por: Arellano, Jorge, et al.
Publicado: (2015)

Surface protein distributions in cells isolated from solid tumours and their metastases.
por: Guy, D., et al.
Publicado: (1979)

Patient–Caregiver Treatment Preference Discordance and Its Association With Caregiving Burden and Esteem
por: Ozdemir, Semra, et al.
Publicado: (2021)

Improvements to Survey Design from Pilot Testing a Discrete-Choice Experiment of the Preferences of Persons Living with HIV for Long-Acting Antiretroviral Therapies
por: Barthold, Douglas, et al.
Publicado: (2022)

Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials
por: Katz, Eva G, et al.
Publicado: (2016)

From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices
por: Boeri, Marco, et al.
Publicado: (2019)

Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes
por: Marinac, Marjana, et al.
Publicado: (2020)

Caregiver perspectives and preferences for acute otitis media management
por: Frost, Holly M., et al.
Publicado: (2021)

A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.S
por: Stewart, Darren E., et al.
Publicado: (2021)

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes
por: Hauber, A Brett, et al.
Publicado: (2013)

Understanding what matters to metastatic castration‐resistant prostate cancer (mCRPC) patients when considering treatment options: A US patient preference survey
por: George, Daniel J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_re3ullu6fsct1pk8m179l5nlbv